Improved Voriconazole Topical Delivery by Nanoparticles (Minireview)
- Авторы: Nassiri-Kashani M.1, Namdar R.2,3, Nafisi S.2,3, Maibach H.I.3
- 
							Учреждения: 
							- Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences
- Department of Chemistry, Central Tehran Branch
- Department of Dermatology, University of California
 
- Выпуск: Том 50, № 2 (2016)
- Страницы: 76-79
- Раздел: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244322
- DOI: https://doi.org/10.1007/s11094-016-1401-6
- ID: 244322
Цитировать
Аннотация
Voriconazole is a triazole antifungal drug used to treat invasive fungal infections including candidiasis, aspergillosis, and certain emerging fungal infections. Voriconazole demonstrates low water solubility. Therefore, drug solubilization is necessary for effective topical delivery. Nano-strategy may overcome its poor aqueous solubility as well as controlled drug release at action site, reduction of total dose, avoidance of systemic absorption and dosage form retention on skin. In topical antifungal administration, drug should pass outermost layer of skin; stratum corneum to reach lower layers, particularly into follicular epithelium. Nano-formulations including colloidal systems, vesicular carriers, and nanoparticles may play a major role for enhancing antifungals permeation profile. Present review surveys key experiments with voriconazole nano-based formulations used in superficial fungal infections treatment.
Ключевые слова
Об авторах
Mansour Nassiri-Kashani
Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences
														Email: maibachh@derm.ucsf.edu
				                					                																			                												                	Иран, 							Tehran						
Roshanak Namdar
Department of Chemistry, Central Tehran Branch; Department of Dermatology, University of California
														Email: maibachh@derm.ucsf.edu
				                					                																			                												                	Иран, 							Tehran, IAU; San Francisco, CA						
Shohreh Nafisi
Department of Chemistry, Central Tehran Branch; Department of Dermatology, University of California
							Автор, ответственный за переписку.
							Email: drshnafisi@gmail.com
				                					                																			                												                	Иран, 							Tehran, IAU; San Francisco, CA						
Howard Maibach
Department of Dermatology, University of California
							Автор, ответственный за переписку.
							Email: maibachh@derm.ucsf.edu
				                					                																			                												                	США, 							San Francisco, CA						
Дополнительные файлы
 
				
			 
						 
					 
						 
						 
						 
									 
  
  
  
  
  Отправить статью по E-mail
			Отправить статью по E-mail  Открытый доступ
		                                Открытый доступ Доступ предоставлен
						Доступ предоставлен Только для подписчиков
		                                		                                        Только для подписчиков
		                                					